The Scientist

» science policy

Most Recent

image: Government Shutdown to Impact Science

Government Shutdown to Impact Science

By | October 1, 2013

The failure of the US Congress to reach consensus on a stopgap spending plan threatens to hobble research at federal agencies and beyond.

0 Comments

image: Proceed with Caution

Proceed with Caution

By | October 1, 2013

While genomic data sharing is essential for research, scientists must work to keep sensitive, potentially damaging information under wraps.

1 Comment

image: Kerfuffle Over Marijuana Claim

Kerfuffle Over Marijuana Claim

By | August 20, 2013

A pro-pot group airs an ad stating marijuana is “less toxic” than alcohol, but a federal science agency disputes the assertion.

7 Comments

image: How the NIH Fuels Private Business

How the NIH Fuels Private Business

By | July 25, 2013

A new report details the ways in which the federal science agency boost the US economy by stimulating the private sector.

0 Comments

image: Gene Patents Decision: Everybody Wins

Gene Patents Decision: Everybody Wins

By | June 18, 2013

Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.

4 Comments

image: Week in Review, June 10–14

Week in Review, June 10–14

By | June 14, 2013

Supreme Court says no patenting (natural) genes; brain-computer interfaces mimic motor learning in brain; regenerating finger tips; gene therapy goes deeper; NIH needs more diversity; cross-border collaboration

0 Comments

image: OA Plan to Appease White House?

OA Plan to Appease White House?

By | June 6, 2013

Scientific publishers come up with a scheme to disseminate publicly funded research in response to a directive from President Obama’s top science advisor.

3 Comments

image: Science-Supporting Senator Dies

Science-Supporting Senator Dies

By | June 4, 2013

Democratic Senator Frank Lautenberg of New Jersey, who fought hard against the alcohol and tobacco industries, has passed away.

0 Comments

image: Opinion: The Payoff of Big Science

Opinion: The Payoff of Big Science

By | June 3, 2013

Was the Human Genome Project the key to a gold mine?

3 Comments

image: Italy Orders Trials of Unproven Therapy

Italy Orders Trials of Unproven Therapy

By | May 23, 2013

Italian lawmakers have demanded formal approval for a controversial stem-cell therapy, but allowed some patients to continue treatment under stricter rules.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech